Cabaletta Bio Inc. (CABA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cabaletta Bio Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.52
+4.47% today
Market cap
$247M
Overall quality
41/100
Kronos AI 30-day
+78.3%
8 of 8 simulated paths end higher
Cabaletta Bio Inc. (CABA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $247M. It trades at $1.52, up 4.47% today. Its overall quality score is 41 out of 100, ranked against the whole US market. 7 analysts' average target of $14.67 implies +865.1% from today's price. Kronos AI's 30-day forecast is +78.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $14.67 |
| Low – high | $3.00 – $30.00 |
| Analysts | 7 |
| Upside to average | +865.1% |
Kronos AI 30-day forecast
| Expected close | $2.59 (+78.3%) |
| Likely range | +66.0% … +89.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 38 |
| Solvency | 56 |
| Growth | 30 |
| Overall | 41 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.